General Coronavirus March 2020
Insights from CBE’s Jeff Davies into how plasma products could help Corona Virus victims. Before joining the Centre for Biopharmaceutical Excellence, Jeff was CSL’s ...
General February 2020
2019 marked significant growth for CBE, as partners expanded their training and projects into Asia and worked with global companies on potential investments and ...
General Consulting February 2020
Perth-based PureIV, a CBE client, has obtained a TGA GMP license for sterile injectable compounding, in a significant breakthrough, mitigating serious potential risks to ...
General November 2019
October was another productive month at CBE, with ongoing reviews, audits and risk assessments. CBE director Alison Mew attended AusBiotech conference that featured several ...
